A New Approach to Treating
Global Infectious Diseases

Strategic Advisory Board

Mahendra Shah, PhD

Mahendra G. Shah, Ph.D. is a highly successful pharmaceutical entrepreneur and executive. From September 2005 to December 2009, he was the founder, chairman and CEO of NextWave Pharmaceuticals, a pediatric focused specialty pharmaceutical company. From 1993 to May 2003 he was the chairman and CEO of First Horizon Pharmaceuticals, a publicly traded specialty pharmaceutical company, where he raised over $200 million and built a very profitable company before it was sold to Shionogi Pharmaceuticals for $1.4 billion. From 1991 to October 1999, he was vice president of E. J. Financial Enterprises, Inc., which manages a fund that invests in healthcare companies.

He previously served on the boards of Unimed Pharmaceuticals (UMED), Introgen Therapeutics (INGN), Inpharmakon, Protomed, Structural Bioinformatics, and Zarix. From 1987 to 1991 he was the senior director of new business development with Fujisawa USA (Astellas). Prior to that time he worked in various scientific and management positions with Schering-Plough and Bristol Myers-Squibb. Dr. Shah received his Ph.D. in industrial pharmacy from St. John's University.

Jeff Guise

Jeff Guise, JD, PhD

Dr. Jeffrey Guise is a partner in the San Diego office of Wilson Sonsini Goodrich & Rosati. Dr. Guise practices in the area of intellectual property law and has extensive experience in all aspects of intellectual property acquisition, licensing, and enforcement. Dr. Guise's intellectual property litigation experience includes pre-trial and trial experience, interference proceedings, and litigation counseling.

Dr. Guise’s intellectual property counseling experience includes drafting non-infringement and validity opinions, freedom-to-operate analyses, and invention records management plans. Dr. Guise’s patent prosecution experience includes drafting and prosecuting U.S. and international patent applications for a wide range of biotechnology, pharmaceutical, immunology, medical diagnostics, genetic engineering, agricultural

biotechnology, genomics, proteomics clients, bioinformatics software, and electronic hardware systems. Dr. Guise also has extensive experience in negotiating and drafting license agreements.

Prior to joining Wilson Sonsini Goodrich & Rosati, Dr. Guise was a partner at Pillsbury Winthrop. Prior to Pillsbury Winthrop, Dr. Guise was a partner at both Brobeck, Phleger & Harrison and Lyon & Lyon.